We report for the first time that altering the microenvironment in this way induced the clinical IBC phenotype, specifically in promoting tumor skin invasion and dermolymphatic tumor emboli formation, the propensity for metastases, and the E-cadherin paradox. The gene discussed is CDH1; the disease is neoplasm.